Data: 08/08/2026
Total encontrado: 3
1/3US=101 / Câncer
Blander JM. Analysis of the TLR/NF-&*1179;B pathway in antigen-presenting cells in malignancies promoted by inflammation. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 99-117. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3.

RECEPTORES TOLL-LIKE; RECONHECIMENTO DE RECEPTORES PADRAO; FATOR NUCLEAR DE &*1179;B; TRANSDUCAO DE SINAL; INFLAMACAO; CANCER; CO-LOCALIZACAO; MARCADORES DE ORGANELAS


2/3US=23 / Clín/Médica
Salomão R, Brunialti MKC, Martins PS. Aspectos imunológicos: reconhecimento e ataque ao antígeno: toll-like receptors, CD14 e padrões moleculares associados a patógenos. In: Silva FP, Velasco IT. Sepse. Barueri: Manole, 2007. p. 177-86. ISBN 85-2042558-5.

RECEPTORES TOLL-LIKE; CD14; SINALIZACAO CELULAR; SEPSE


3/3US=47 / Clín/Medica
Camdore G, Balistreri CR, Grinaldi MP, Vasto S, Listi F, Chiappelli M, Licastro F, Lio D, Caruso C. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 472-86. ISBN 978-1-57331-699-5.

DOENCA DE PARKINSON; GENETICA; INFLAMACAO; ESTROGENIOS; CD14; RECEPTORES TOLL-LIKE; CYCLOOXYGENASES; LIPOXIGENASES